Mates Sharon 4
4 · Benitec Biopharma Inc. · Filed Dec 3, 2025
Insider Transaction Report
Form 4
Mates Sharon
Director
Transactions
- Award
Options (right to buy)
2025-12-01+3,500→ 3,500 totalExercise: $12.23Exp: 2035-12-01→ Common Stock (3,500 underlying)
Footnotes (1)
- [F1]The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.